Sandbox/table: Difference between revisions
< Sandbox
Created page with " {| class="wikitable" |+ Countries with a reported prevalence <15% of ''H. pylori'' resistance to clarithromycin ! Europe !! North America !! South America !! Middle East !! ..." |
No edit summary |
||
Line 1: | Line 1: | ||
{| | {| style="border: 2px solid #DCDCDC; font-size: 90%; width: 80%;" | ||
|+ Countries with a reported prevalence <15% of ''H. pylori'' resistance to clarithromycin | |+ Countries with a reported prevalence <15% of ''H. pylori'' resistance to clarithromycin | ||
! Europe ! | ! style="background: #DCDCDC;" | Europe | ||
! style="background: #DCDCDC;" | North America | |||
! style="background: #DCDCDC;" | South America | |||
! style="background: #DCDCDC;" | Middle East | |||
! style="background: #DCDCDC;" | Far East | |||
|- | |- | ||
| Bulgaria (8.7%) | | style="background: #F5F5F5; padding: 0 10px; width: 20%;" valign=top | | ||
* Bulgaria (8.7%) | |||
* Croatia (8%) | |||
* Germany (2.2–4%) | |||
* Italy (North) (1.8%) | |||
* Netherlands (1.7%) | |||
| | * Spain (12.9%) | ||
* Sweden (2.9%) | |||
* UK (3.9–4.4%) | |||
| | | style="background: #F5F5F5; padding: 0 10px; width: 20%;" valign=top | | ||
* USA (10.6–12.2%) | |||
| style="background: #F5F5F5; padding: 0 10px; width: 20%;" valign=top | | |||
* Brazil (9.8%) | |||
| style="background: #F5F5F5; padding: 0 10px; width: 20%;" valign=top | | |||
* Israel (8.2%) | |||
| style="background: #F5F5F5; padding: 0 10px; width: 20%;" valign=top | | |||
* Hong Kong (4.5%) | |||
* Japan (11–12.9%) | |||
* Korea (5.4–5.9%) | |||
* New Zealand (6.8%) | |||
|} | |} |
Revision as of 19:52, 4 June 2014
Europe | North America | South America | Middle East | Far East |
---|---|---|---|---|
|
|
|
|
|